期刊
NEUROREPORT
卷 15, 期 1, 页码 207-210出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001756-200401190-00040
关键词
alcohol withdrawal; anxiety; chronic intermittent ethanol; hyperexcitability; kindling; pentylentetrazol; topiramate
资金
- NIAAA NIH HHS [AA07680] Funding Source: Medline
Topiramate, a novel anticonvulsant drug, has CNS depressant activity including enhancement of GABAergic inhibitory synaptic transmission. Drugs of this pharmacological spectrum might have utility in assuaging drug addiction. This study analyzes the ability of TPM to reduce withdrawal signs in the kindling model of ethanol dependence: chronic intermittent ethanol (CIE) rats. After CIE, persistent withdrawal signs are shown by an increased seizure susceptibility to the convulsant drug pentylenetetrazol and increased anxiety measured on the elevated plus-maze. Topiramate increased significantly the PTZ seizure threshold in CIE but not in control rats. On the elevated plus-maze, Topiramate was markedly more effective in CIE rats than in controls. Topiramate may have a therapeutic efficacy in treating alcohol withdrawal symptoms.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据